Latest Breaking News On - Lal pathlabs - Page 1 : comparemela.com

Temasek and MOPE-backed Molbio Diagnostics kickstarts IPO prep, aims Rs 22,000-24,000 cr valuation

Block deals worth over Rs 13,000 crore this week: Adani Ports, HDFC Bank, Vodafone Idea among stocks with top action

The week gone by was highly volatile, with Nifty gaining 2.2% or 490 points in four sessions and hitting a lifetime high of 23,000. The week was also in the news for block deals involving over three dozen companies from large, mid and smallcap segments worth Rs 13,059 crore on screen.

market: Expect 15-18% upside in Sun Pharma over medium to long term: Hemang Jani

Sun Pharma numbers were slightly below expectations in terms of EBITDA and we do think that though they have guided for a very strong growth through their speciality portfolio, that is a little bit time away.

Indian diagnostics sector set for 8-9% CAGR growth, predict analysts

This resurgence is expected to be fuelled by increased testing, strategic price adjustments, expansion of wellness services, says report by HDFC Securities

Firms need private equity money to grow, but can't expect overnight success: Dr Lal PathLabs' Arvind Lal